These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 1397042

  • 1. Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier.
    Bui JD, Kimura B, Phillips MI.
    Eur J Pharmacol; 1992 Aug 14; 219(1):147-51. PubMed ID: 1397042
    [Abstract] [Full Text] [Related]

  • 2. The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin.
    Hogarty DC, Speakman EA, Puig V, Phillips MI.
    Brain Res; 1992 Jul 24; 586(2):289-94. PubMed ID: 1521162
    [Abstract] [Full Text] [Related]

  • 3. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.
    Culman J, von Heyer C, Piepenburg B, Rascher W, Unger T.
    Eur J Pharmacol; 1999 Feb 19; 367(2-3):255-65. PubMed ID: 10079000
    [Abstract] [Full Text] [Related]

  • 4. Effects of a non-peptide angiotensin receptor antagonist on drinking and blood pressure responses to centrally administered angiotensins in the rat.
    Kirby RF, Thunhorst RL, Johnson AK.
    Brain Res; 1992 Apr 03; 576(2):348-50. PubMed ID: 1515929
    [Abstract] [Full Text] [Related]

  • 5. Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in rats.
    Polidori C, Ciccocioppo R, Pompei P, Cirillo R, Massi M.
    Eur J Pharmacol; 1996 Jul 04; 307(3):259-67. PubMed ID: 8836613
    [Abstract] [Full Text] [Related]

  • 6. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
    Morita O, Kushida H, Kunihara M.
    J Cardiovasc Pharmacol; 1995 Jun 04; 25(6):880-7. PubMed ID: 7564332
    [Abstract] [Full Text] [Related]

  • 7. Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the rat.
    Li Z, Bains JS, Ferguson AV.
    Brain Res Bull; 1993 Jun 04; 30(1-2):33-9. PubMed ID: 8420632
    [Abstract] [Full Text] [Related]

  • 8. Functional role of brain AT1 and AT2 receptors in the central angiotensin II pressor response.
    Toney GM, Porter JP.
    Brain Res; 1993 Feb 12; 603(1):57-63. PubMed ID: 8453478
    [Abstract] [Full Text] [Related]

  • 9. Effects of blockade of AT1 and AT2 receptors in brain on the central angiotensin II pressor response in conscious spontaneously hypertensive rats.
    Toney GM, Porter JP.
    Neuropharmacology; 1993 Jun 12; 32(6):581-9. PubMed ID: 8336821
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Functional roles of brain AT1 and AT2 receptors in the central angiotensin II pressor response in conscious young spontaneously hypertensive rats.
    Toney GM, Porter JP.
    Brain Res Dev Brain Res; 1993 Feb 19; 71(2):193-9. PubMed ID: 8491041
    [Abstract] [Full Text] [Related]

  • 14. The role of brain angiotensin in thirst and AVP release induced by hemorrhage.
    Phillips MI, Heininger F, Toffolo S.
    Regul Pept; 1996 Oct 08; 66(1-2):3-11. PubMed ID: 8899885
    [Abstract] [Full Text] [Related]

  • 15. Acute and chronic effects of losartan (DuP 753) on blood pressure and vascular reactivity in normotensive rats.
    Soltis EE, Jewell AL, Dwoskin LP, Cassis LA.
    Clin Exp Hypertens; 1993 Jan 08; 15(1):171-84. PubMed ID: 8467311
    [Abstract] [Full Text] [Related]

  • 16. Competitive antagonism of pressor responses to angiotensin II and angiotensin III by the angiotensin II-1 receptor ligand losartan.
    Abdelrahman A, Pang CC.
    Can J Physiol Pharmacol; 1992 May 08; 70(5):716-9. PubMed ID: 1423014
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
    Bunting MW, Widdop RE.
    Br J Pharmacol; 1995 Dec 08; 116(8):3181-90. PubMed ID: 8719794
    [Abstract] [Full Text] [Related]

  • 19. Access of peripherally administered DuP 753 to rat brain angiotensin II receptors.
    Song KF, Zhuo JL, Mendelsohn FA.
    Br J Pharmacol; 1991 Dec 08; 104(4):771-2. PubMed ID: 1810594
    [Abstract] [Full Text] [Related]

  • 20. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    Siegl PK, Chang RS, Mantlo NB, Chakravarty PK, Ondeyka DL, Greenlee WJ, Patchett AA, Sweet CS, Lotti VJ.
    J Pharmacol Exp Ther; 1992 Jul 08; 262(1):139-44. PubMed ID: 1625193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.